• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON AND CO. 10 ML BD POSIFLUSH¿ SF SALINE SYRINGE; SALINE FLUSH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON AND CO. 10 ML BD POSIFLUSH¿ SF SALINE SYRINGE; SALINE FLUSH Back to Search Results
Catalog Number 306553
Device Problems Device Packaging Compromised (2916); Moisture or Humidity Problem (2986)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 02/16/2018
Event Type  malfunction  
Manufacturer Narrative
Date of event: unknown.The date received by manufacturer has been used for this field.Six potential lot numbers were provided for this incident.The information for each lot number is as follows: medical device lot #: 6264805, medical device expiration date: 08/31/2019, device manufacture date: 09/20/2016.Medical device lot #: 7130684, medical device expiration date: 2020, device manufacture date: 05/10/2017.Medical device lot #: 7170621, medical device expiration date: 05/31/2020, device manufacture date: 06/19/2017.Medical device lot #: 7244896, medical device expiration date:08/31/ 2020, device manufacture date: 09/01/2017.Medical device lot #: 7277539, medical device expiration date: 09/30/2020, device manufacture date: 10/04/2017.Medical device lot #: 7319531, medical device expiration date: 10/31/2020, device manufacture date: 11/15/2017.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that the packaging on a 10 ml bd posiflush¿ sf saline syringe was found with a ¿yellow¿ discoloring and looked and felt like it was wet.There was no report of exposure, injury or medical intervention.
 
Manufacturer Narrative
Investigation results: a no sample investigation was completed by our quality engineer team.Upon review of the reported information, the discoloration of the syringe packaging was confirmed for all of the provided lot numbers.The stains occur as a result the interaction between the paper and the moist heat sterilization process.Test results have confirmed the stains are cosmetic only in nature and do not permeate through the packaging to the product.Microbial permeability testing, cytotoxicity testing, and testing for residual solvents and volatile species has been completed on the packages displaying the brownish stain.The testing confirmed that they do not present any risk to the use of the product and have no impact on the effectiveness, sterility, quality, or safety of bd posiflush sf 10ml saline flush syringe.A review of the production history showed no rejected inspections or quality issues for any of the provided lot numbers that could have contributed to this defect.Syringe discoloration, lots 6264805, 7130684, 7170621, 7244896 7277539, & 7319531 no sample received.Dhr 6264805: there were no non-conformances relating to this defect.Dhr 7319531: there were no non-conformances relating to this defect.Dhr 7277539: there were no non-conformances relating to this defect.Dhr 7244896: there were no non-conformances relating to this defect.Dhr 7170621: there were no non-conformances relating to this defect.Dhr 7130684: there were no non-conformances relating to this defect.Risk assessment: in 2017, for this defect type, complaints were reported at an average of 3 per month.Occurrence rate varies between customers, but a total of 26 have been recorded for this specific defect from january to august 2017.Corrective action: required.Capa (b)(4) has been raised following unit level discussions in september 2017.Exceptions: lot numbers manufactured prior to lot 6315951 may have associated staining complaints as a result of sterilizer component issues.This was addressed in capa (b)(4) and the associated corrective action was implemented november 2016.Lot number 6315951 was the first lot number manufactured post corrective action implementation.Lot numbers prior to lot 6315951 may generate customer complaints for staining, these complaints are not within scope of this pic and shall be addressed on an individual basis.A corrective action plan has been implemented to reduce the presence of the brown packaging stains.As no samples were received, bd was unable to confirm the defect of syringe discoloration.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
10 ML BD POSIFLUSH¿ SF SALINE SYRINGE
Type of Device
SALINE FLUSH
Manufacturer (Section D)
BECTON, DICKINSON AND CO.
donore road
drogheda
MDR Report Key7332288
MDR Text Key102326980
Report Number9616657-2018-00008
Device Sequence Number1
Product Code NGT
UDI-Device Identifier30382903065531
UDI-Public30382903065531
Combination Product (y/n)N
PMA/PMN Number
K153481
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,other,use
Type of Report Initial,Followup
Report Date 04/17/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number306553
Device Lot NumberSEE SECTION H.10.
Initial Date Manufacturer Received 02/16/2018
Initial Date FDA Received03/12/2018
Supplement Dates Manufacturer Received02/16/2018
Supplement Dates FDA Received04/17/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-